Apr 13,2020

Cipla-backed Wellthy Therapeutics raises $4 million led by Saama Capital

Mumbai-based digital therapeutics startup Wellthy Therapeutics said it has raised $4 million (around ₹30 crore) from Saama Capital, as part of its Pre-Series A round, for a 16% stake in the company. Wellthy Therapeutics will use the funds to enhance product suite, for international expansion of its business and to expand into newer therapy areas.

FUNDING PRE-SERIES A
View Analyst & Ambassador Comments
Go to original news
Apr 24,2020

Cecelia Health Receives $2.5M Debt Finance

Cecelia Health received $2.5 million fuding in debt financing according to the SEC form registered.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Apr 30,2020

Vida Health raises $25 million to scale network and meet increased demand for virtual care

Virtual healthcare platform, Vida Health, announced today that it raised $25 million in new funding to meet the increased demand for mental and physical virtual care. The funding was led by Ally Bridge Group (ABG), a leading global life science investment firm.

FUNDING VENTURE ROUND
View Analyst & Ambassador Comments
Go to original news
May 11,2020

CARBON HEALTH RAISES $28 MILLION IN SERIES B1, TRIPLES STAFF, BEGINS NATIONAL VIRTUAL CARE ROLLOUT

Carbon Health, the technology-enabled healthcare provider designed from the ground up to put patient-care first, announced today that it has tripled its headcount to combat the COVID-19 pandemic and extended its virtual care service to now serve nearly two-thirds of the U.S. population. The growth was made possible by its recent strategic round of funding of $28 million led by existing investor DCVC in an extended Series B, bringing the company’s total raised capital to $75 million.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 19,2020

Omada Health scores $57 million as coronavirus pandemic sparks investor interest in health tech

Omada Health is capitalizing on the sudden interest from investors. The company just pulled in $57 million from investment fund Perceptive Advisors, which focuses on health and life sciences, and it used some of that money to buy a smaller digital health start-up called Physera, which specializes in virtual physical therapy. Approximately $30 million of the total sum was used for the acquisition, a person familiar with the deal told CNBC.

FUNDING VENTURE ROUND
View Analyst & Ambassador Comments
Go to original news
Jun 25,2020

Gendius diabetes AI development awarded £50,000

The Momentum Fund was established to support the introduction and adoption of needs-led, evidence-based innovations into the healthcare system within Greater Manchester. AI tool from Gendius to support patients to manage their diabetes, a clinical decision platform to help with earlier discharges from the Emergency Department and an online system to match clinician availability to patient needs in real-time were among four winners set to receive a share of £200,000 to improve health and care in Greater Manchester. Gendius have developed the Intellin app, which uses AI to calculate an individual’s risk of developing complications from their diabetes based on their clinical history.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Jul 24,2020

Diabetes Management Platform Gendius Hits 250,000 Downloads as Latest Crowdcube Funding Round Overfunds

Gendius, a UK-based diabetes research company, has successfully raised 300,000 through its latest equity crowdfunding campaign on Crowdcube. The funding round comes less than a year after Gendius raised more than 500,000 through its first Crowdcube initiative.

FUNDING EQUITY CROWDFUNDING
View Analyst & Ambassador Comments
Go to original news
Aug 10,2020

Senseonics Announces a Financing Agreement with Master Special Situations, LLC on the Heels of Strategic Partnership with PHC Holdings Corporation

The company also announced a concurrent financing agreement with PHC Holdings Corporation, the parent company of Ascensia. In addition, Senseonics also announced a financing agreement with Masters Special Situations, LLC and affiliates thereof (“MSS”). The financing arrangements collectively provide for a total of up to $80 million of debt and equity capital, as $50 million invested by the PHC Holdings.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Aug 10,2020

Senseonics Announces Strategic Collaboration with Ascensia Diabetes Care

Senseonics Holdings today announced the formation of a strategic partnership with Ascensia Diabetes Care, through a commercialization and collaboration agreement, which will make Ascensia the exclusive worldwide distributor of Senseonics’ Eversense® CGM systems. Ascensia’s parent company, PHC Holdings Corporation, will also provide up to $50 million to Senseonics through (i) the purchase of $35 million in aggregate principal amount of convertible debt securities in a transaction expected to close on or about August 14, 2020 and (ii) a commitment to purchase up to an additional $15 million in convertible preferred stock, at Senseonics’ option and contingent upon FDA approval of the 180-day Eversense sensor in the U.S..

FUNDING POST-IPO DEBT
View Analyst & Ambassador Comments
Go to original news
Sep 15,2020

Brighter receives SEK 21.7 million from exercise of TO4 warrants

The final exercise period for Brighter’s TO4 warrants is now completed. The company receives SEK 21.7 million and the number of shares increases by 10,867,670, to a total of 209,904,250 shares. With this, Brighter TO4 warrants ceases to exist.

FUNDING POST-IPO DEBT
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES